Assembly Biosciences Inc — Balance Sheet (NASDAQ:ASMB) | MetaTrader

Open full chart

Financials

Overview 声明 Statistics Dividends

Quarterly Annual

Total assets 283.25 M191.06 M101.79 M136.82 M119.17 M Total liabilities 42.68 M22.13 M19.13 M95.73 M85.81 M Total equity 240.58 M168.93 M82.66 M41.1 M33.36 M Total liabilities & shareholders' equities 283.25 M191.06 M101.79 M136.82 M119.17 M Total debt ————— Net debt —————

新闻

Personalis (PSNL) Reports Q4 Loss, Misses Revenue Estimates

Supernus Pharmaceuticals (SUPN) Surpasses Q4 Earnings and Revenue Estimates

GILD Exercises Option to License Assembly Bio's Herpes Programs

Gilead Sciences Bets On Weekly Pill To Tackle Genital Herpes - Assembly Biosciences (NASDAQ:ASMB), Gilead Sciences (NASDAQ:GILD)

Gilead exercises option for Assembly Bio’s herpes treatment programs

Jefferies上调Assembly Biosciences目标价至62美元，基于HSV数据

Jefferies raises Assembly Biosciences stock price target to $62 on HSV data

Assembly Biosciences, Inc. (ASMB) Discusses Positive Interim Results for ABI-1179 and ABI-5366 in Recurrent Genital Herpes Phase 1b Studies Transcript

Assembly Biosciences, Inc. (ASMB) Discusses Positive Interim Results for ABI-1179 and ABI-5366 in Recurrent Genital Herpes Phase 1b Studies - Slideshow (NASDAQ:ASMB) 2025-12-08

Assembly Biosciences股价在HSV药物取得良好结果后上涨

Assembly Biosciences stock rises after promising HSV drug results

Assembly Bio在临床试验中报告HSV治疗取得强劲结果